Literature DB >> 10844229

The effects of bovine viral diarrhoea virus on cattle reproduction in relation to disease control.

M D Fray1, D J Paton, S Alenius.   

Abstract

Bovine viral diarrhoea virus (BVDV) is a major reproductive pathogen in cattle. Infection of the bull can lead to a fall in semen quality and the isolation of infectious virus in the ejaculate, while infection in the cow leads to poor conception rates, abortions and congenital defects. BVDV also reduces the animal's resistance to other respiratory and enteric pathogens. The prevalence of BVDV is primarily due to the efficiency with which the virus crosses the placenta of susceptible females. Calves that survive infection during the first trimester of pregnancy are born with a persistent and lifelong infection. These persistently infected (PI) animals represent between 1.0% and 2.0% of the cattle population and continuously shed infectious virus. The availability of reliable diagnostic ELISA and PCR techniques, which can test milk or serum samples for virus or antibodies, has simplified BVDV surveillance and improved the prospects for control. Although PI animals are the principal vectors within and between herds, they can be readily identified and removed. By contrast, cows carrying a PI foetus are particularly problematic. These animals have been compared to 'Trojan Horses' because they are virus-negative and antibody-positive but they deliver PI calves. In general, acutely infected cattle are much less efficient vectors but infections at the onset of puberty have resulted in a localised and persistent infection within the testes. Under these circumstances, virus shedding into the semen may remain undetected. Transmission of BVDV can be controlled through vaccination or eradication. BVDV vaccine technology has been developing over the past 30 years, but currently available vaccines are still of the conventional inactivated or attenuated sort. In general, vaccination has not been applied with sufficient rigor to make a significant impact on the level of circulating virus, unlike the national and regional eradication programmes established in areas such as Scandinavia, Austria, the Netherlands and Scotland. Eradication confers the added advantage of improved herd health; however, it also creates a susceptible cattle population that needs to be protected by stringent biosecurity. In this article, we discuss how BVDV influences reproductive function, the potential for viral transmission during breeding and the measures that must be taken to avoid the spread of infection to susceptible cattle populations via semen, embryos, culture fluids and infected cows.

Entities:  

Mesh:

Year:  2000        PMID: 10844229     DOI: 10.1016/s0378-4320(00)00082-8

Source DB:  PubMed          Journal:  Anim Reprod Sci        ISSN: 0378-4320            Impact factor:   2.145


  28 in total

1.  Seroprevalence and factors associated with bovine viral diarrhea virus (BVDV) infection in dairy cattle in three milksheds in Ethiopia.

Authors:  Kassaye Aragaw; Berhanu Sibhat; Gelagay Ayelet; Eystein Skjerve; Endrias Z Gebremedhin; Kassahun Asmare
Journal:  Trop Anim Health Prod       Date:  2018-05-31       Impact factor: 1.559

Review 2.  Persistent bovine viral diarrhea virus (BVDV) infection in cattle herds.

Authors:  A Khodakaram-Tafti; G H Farjanikish
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

3.  Not all cows are epidemiologically equal: quantifying the risks of bovine viral diarrhoea virus (BVDV) transmission through cattle movements.

Authors:  M Carolyn Gates; Roger W Humphry; George J Gunn; Mark E J Woolhouse
Journal:  Vet Res       Date:  2014-10-17       Impact factor: 3.683

4.  First isolation and molecular characterization of pseudorabies virus detected in Turkey.

Authors:  Gizem Aytogu; Eda B Toker; Ozkan Yavas; Berfin Kadiroglu; Ozer Ates; Musa Ozgur Ozyigit; Kadir Yesilbag
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

5.  Design, expression, and purification of a Flaviviridae polymerase using a high-throughput approach to facilitate crystal structure determination.

Authors:  Kyung H Choi; James M Groarke; Dorothy C Young; Michael G Rossmann; Daniel C Pevear; Richard J Kuhn; Janet L Smith
Journal:  Protein Sci       Date:  2004-10       Impact factor: 6.725

6.  Sequential exposure to bovine viral diarrhea virus and bovine coronavirus results in increased respiratory disease lesions: clinical, immunologic, pathologic, and immunohistochemical findings.

Authors:  Julia F Ridpath; Robert W Fulton; Fernando V Bauermann; Shollie M Falkenberg; Jenny Welch; Anthony W Confer
Journal:  J Vet Diagn Invest       Date:  2020-06-02       Impact factor: 1.279

7.  Seroconversion to bovine viral diarrhoea virus and infectious bovine rhinotracheitis virus in dairy herds of Michoacan, Mexico.

Authors:  José C Segura-Correa; José L Solorio-Rivera; Laura G Sánchez-Gil
Journal:  Trop Anim Health Prod       Date:  2009-08-15       Impact factor: 1.559

8.  The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation.

Authors:  Louise Hilton; Kartykayan Moganeradj; Gang Zhang; Yun-Hsiang Chen; Richard E Randall; John W McCauley; Stephen Goodbourn
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

Review 9.  Recent Advances on the Bovine Viral Diarrhea Virus Molecular Pathogenesis, Immune Response, and Vaccines Development.

Authors:  Anwar A G Al-Kubati; Jamal Hussen; Mahmoud Kandeel; Abdullah I A Al-Mubarak; Maged Gomaa Hemida
Journal:  Front Vet Sci       Date:  2021-05-14

10.  Transplacental transmission of bluetongue virus 8 in cattle, UK.

Authors:  Karin E Darpel; Carrie A Batten; Eva Veronesi; Susanna Williamson; Peter Anderson; Mike Dennison; Stuart Clifford; Ciaran Smith; Lucy Philips; Cornelia Bidewell; Katarzyna Bachanek-Bankowska; Anna Sanders; Abid Bin-Tarif; Anthony J Wilson; Simon Gubbins; Peter P C Mertens; Chris A Oura; Philip S Mellor
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.